[bencoder]

Not sure if you're posting this as a disagreement with the suggested model, or agreeing.

From the link, it looks like it costs ~$10bn per successful drug, at the top end of that list.

Australia paid $750m for 5 years access.

Australia has ~1/10th the population of the United States. and ~1/3rd the population of the UK.

If just the UK, USA and Australia paid at that same rate (per capita) then they would cover that 10bn average development cost in 5 years.

Seems like it's a good suggestion

[ummonk]

I imagine the Hep C drugs are some of the more monetizable drugs though and will need to rake in more money to subsidize the development of niche drugs.